Contraindicated in:
Use Cautiously in:
CV: QT interval prolongation, heart block, HF, TORSADES DE POINTES.
Derm: acute generalized exanthematous pustulosis, alopecia, DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), ERYTHEMA MULTIFORME, hair color changes, hyperpigmentation, photosensitivity, pruritus, rash, STEVENS-JOHNSON SYNDROME (SJS), TOXIC EPIDERMAL NECROLYSIS, urticaria.
EENT: corneal deposits, nystagmus, retinopathy, tinnitus, vertigo, visual disturbances.
Endo: hypoglycemia.
GI: ↑ liver enzymes, abdominal pain, anorexia, diarrhea, HEPATOTOXICITY, nausea, vomiting.
GU: proteinuria.
Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, leukopenia, thrombocytopenia.
Metab: ↓ weight.
Neuro: aggressiveness, anxiety, ataxia, dizziness, dyskinesia, dystonia, fatigue, headache, irritability, neuromyopathy, nightmares, peripheral neuritis, personality changes, psychoses, SEIZURES, SUICIDAL THOUGHTS/BEHAVIORS, tremor.
Resp: bronchospasm, PULMONARY HYPERTENSION.
Misc: ANGIOEDEMA.
Drug-Drug:
Malaria
Rheumatoid Arthritis
Lupus Erythematosus
Spectrum:
Absorption: Highly variable (31100%) following oral administration.
Distribution: Widely distributed; high concentrations in RBCs; crosses the placenta; excreted into breast milk.
Metabolism/Excretion: Partially metabolized by the liver to active metabolites; partially excreted unchanged by the kidneys.
Half-life: 40 days.
(plasma concentrations)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | rapid | 12 hr | dayswk |
Onset of antirheumatic action may take 6 wk.
NDC Code*